SCHEMBL6162382

SCHEMBL6162382

COC(=O)CNC(=O)C(N)Cc1ccccc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC7A5 Q01650 2/20 0.53
ALPI P09923 1/20 0.53
PKM P14618 1/20 0.53
PTGS1 P23219 1/20 0.53
XIAP P98170 1/20 0.53
OPRK1 P41145 2/20 0.50
CTSC P53634 1/20 0.50
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2D6 P10635 1/20 0.50
CYP2C9 P11712 1/20 0.50
CYP2C19 P33261 1/20 0.50
ABCC3 O15438 1/20 0.50
NR1I2 O75469 1/20 0.50
ABCB11 O95342 1/20 0.50
NR3C1 P04150 1/20 0.50
RARG P13631 1/20 0.50
CNR1 P21554 1/20 0.50
NR1H2 P55055 1/20 0.50
PPARA Q07869 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7635307 1.00 SLC7A5 (0.53) SLC7A5ALPIPKMPTGS1XIAP
Hydrochloric Acid SCHEMBL11202440 0.98 SLC7A5 (0.51) SLC7A5ALPIPKMPTGS1XIAP
Hydrochloric Acid SCHEMBL11202436 0.98 SLC7A5 (0.51) SLC7A5ALPIPKMPTGS1XIAP
SCHEMBL5020123 0.87 PPID (0.58) SLC7A5ALPIPKMPTGS1XIAP
SCHEMBL7277531 0.87 CTSS (0.49) SLC7A5ALPIPKMPTGS1XIAP
SCHEMBL25411191 0.87 CTSS (0.49) SLC7A5ALPIPKMPTGS1XIAP
SCHEMBL29516724 0.87 CTSC (0.48) SLC7A5ALPIPKMPTGS1XIAP
SCHEMBL10588395 0.87 SLC7A5 (0.53) SLC7A5OPRK1MMP2OPRD1OPRM1
Bromide SCHEMBL10788649 0.86 PPID (0.57) SLC7A5ALPIPKMPTGS1XIAP
Bromide SCHEMBL11019745 0.86 PPID (0.57) SLC7A5ALPIPKMPTGS1XIAP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102864196-B Method for preparing alpha-aspartyl small peptide by dihydroorotic acid enzyme method NANJING UNIVERSITY OF TECHNOLOGY 2014-07-02 CN disclosed
CN-102864196-A Method for preparing alpha-aspartyl small peptide by dihydroorotic acid enzyme method NANJING UNIVERSITY OF TECHNOLOGY 2013-01-09 CN disclosed
EP-1134213-B1 Process for the preparation of substituted N-(indole-2-carbonyl)- glycinamides PFIZER (US) 2005-11-02 EP disclosed
EP-0832065-B1 SUBSTITUTED N-(INDOLE-2-CARBONYL)-GLYCINAMIDES AND DERIVATIVES AS GLYCOGEN PHOSPHORYLASE INHIBITORS PFIZER (US) 2001-10-10 EP disclosed
EP-1134213-A2 Process for the preparation of substituted N-(indole-2-carbonyl)- glycinamides PFIZER INC. (US) 2001-09-19 EP disclosed
US-6277877-B1 GLYCOGEN PHOSPHORYLASE INHIBITOR; ANTIDIABETIC AGENTS PFIZER, INC. 2001-08-21 US disclosed
US-6107329-A HYPOTENSIVE AGENTS; CARDIOVASCULAR DISORDERS PFIZER, INC. (US) 2000-08-22 US disclosed
EP-0832065-A1 SUBSTITUTED N-(INDOLE-2-CARBONYL)-GLYCINAMIDES AND DERIVATIVES AS GLYCOGEN PHOSPHORYLASE INHIBITORS PFIZER INC. (US) 1998-04-01 EP disclosed
CN-1142492-A Substituted N-(indole-2-carbonyl)-glycinamides and derivatives as antidiabetic agents PFIZER (US) 1997-02-12 CN disclosed
WO-1996039384-A1 SUBSTITUTED N-(INDOLE-2-CARBONYL)-GLYCINAMIDES AND DERIVATIVES AS GLYCOGEN PHOSPHORYLASE INHIBITORS PFIZER, INC. (US) 1996-12-12 WO disclosed